• Complain

Susan Y Smith - Bone Toxicology

Here you can read online Susan Y Smith - Bone Toxicology full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. year: 2018, publisher: Springer, genre: Children. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

Susan Y Smith Bone Toxicology

Bone Toxicology: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Bone Toxicology" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

The content of this book is intended to provide the toxicologist in drug development in the pharmaceutical and biotechnology industries with a broad understanding of bone and its interactions with other organ systems in safety assessments. The book is divided into three parts. The first part describes our current understanding of bone biology and its primary regulatory pathways. Additional chapters address regulatory and study design considerations for incorporating bone end points in toxicology studies, with special consideration being given to juvenile toxicology studies. This is intended to address recent regulatory requirements to evaluate skeletal development for drugs in development for pediatric populations. The second part of the book describes the principal techniques and methods used in bone research; understanding how these end-points are derived is fundamental to their appropriate application. These first two parts of the book provide the background and the means to develop the concepts in part three which describes bone and its interaction with other organ systems. The unique series of chapters in part three, contributed to by key leaders in their respective fields and in bone research, provides a comprehensive collective work. Although constantly evolving, the crosstalk and interaction of the skeleton with several organ systems is now recognized and well documented, such as for the reproductive system, muscle and kidney, while our understanding of the interaction with other organ systems, such as the immune system and CNS, is in its infancy. Recent work highlights the key role of the skeleton in the regulation of energy metabolism and the impact this has on research in metabolic diseases such as obesity and diabetes. The hope is that this book will enlighten many and encourage more to explore the impact of new compounds on the skeleton in the development of effective and safe drugs.

Susan Y Smith: author's other books


Who wrote Bone Toxicology? Find out the surname, the name of the author of the book and a list of all author's works by series.

Bone Toxicology — read online for free the complete book (whole text) full work

Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Bone Toxicology" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

Light

Font size:

Reset

Interval:

Bookmark:

Make
Part I
Bone Toxicology in Preclinical Drug Testing
Springer International Publishing AG 2017
Susan Y. Smith , Aurore Varela and Rana Samadfam (eds.) Bone Toxicology Molecular and Integrative Toxicology
1. Introduction and Considerations in Bone Toxicology
Susan Y. Smith 1 , Nancy Doyle 2 and Melanie Felx 2
(1)
SY Smith Consulting, Montreal, QC, Canada
(2)
Charles River, 22022, Transcanadienne, Senneville, QC, Canada
Susan Y. Smith
Email:
Abstract
This chapter is intended to provide the researcher with information to facilitate in the design, execution, and interpretation of studies with bone end-points. The ability to use our knowledge of bone biology to ensure study conditions are optimal to detect an effect will be presented. This includes study design considerations and the utility of other models to explore the impact new compounds may have on the skeleton in the development of safe and effective drugs.
Keywords
Regulatory Toxicology Safety Bone end-points Markers Radiography Bone densitometry Histomorphometry Biomechanics Study design Bone quality Adversity
1.1 Introduction
Bone end-points can be included in any safety study design, for any species, at any age, irrespective of duration and route of administration. Additional mechanistic studies can also be designed on a case-by-case basis to meet regulatory demands. The ability to use our knowledge of bone biology to ensure study conditions are optimal to detect an effect is key to a successful outcome. This includes study design considerations, the utility of animal models (chemically, genetically, or surgically modified) in a safety assessment setting, and the potential benefit of including in vitro studies and studies using nonmammalian species (such as zebra fish). These studies cannot only provide invaluable mechanistic data but also respect the three Rs initiative and the ethical use of animals.
This chapter will also tackle the issue of skeletal adversity. One of the most difficult aspects of interpreting the relevance of a skeletal effect is to understand what constitutes a direct effect on bone and what might be considered secondary to effects on growth and body weight. This is a considerable challenge in therapeutic areas such as diabetes and obesity, for example, where the intended pharmacological outcome is likely to impact body weight in non-diseased animals. Animal health and welfare is always the primary concern and of relevance in studies which may become confounded by exaggerated pharmacological effects. Therefore, strategies for mitigating effects of exaggerated pharmacology are important considerations in study design.
The term bone quality has many definitions and is often used as a black box when unknown factors affect bone strength, which is a product of both bone quantity and bone quality. Bone quality encompasses all the geometric and material factors that contribute to fracture resistance (Donnelly ). End-points used to assess skeletal integrity therefore need to characterize the bone geometry and microarchitecture, assess the mechanical properties, and evaluate its tissue composition. No single method can address all aspects of bone quality, but a combination of techniques can help to provide a comprehensive evaluation. The toolbox available in a preclinical setting can be extensive; therefore, the methods used to assess bone should be tailored to the study design and the outcome measures of interest.
1.2 Regulatory Considerations
The primary outcome measures used preclinically to identify and characterize the bone quality are biochemical markers, radiography/bone densitometry, histopathology/histomorphometry, and biomechanics. The selection of these end-points has largely been driven by the requirements or guidelines issued by the regulatory agencies to test drugs intended to treat or prevent osteoporosis (osteoporosis testing guidelines : Japanese MHLW (Skeletal Imaging).
To date, qualitative histopathology remains the gold standard for diagnostic pathology and hazard identification in the safety assessment of potential new therapeutics, but it is not sensitive to evaluate changes in bone mass, geometry, and density. For diagnostic terminology used to describe bone changes, the reader is referred to the INHAND initiative publication devoted to skeletal tissues and teeth of laboratory rats and mice (Fossey et al..
Table 1.1
Recommendations for bone retention in toxicology studiesa
Bone
Potential use
Storage
Rodent/non-rodent
Tibia, proximal
Histomorphometry/micro-CT
NBF then alcohol
Lumbar vertebrae L2 (NHP), L3
Histomorphometry
NBF then alcohol
Lumbar vertebrae L4, L5b
Biomechanics
Frozen 20 C
Femur, whole
Biomechanics
Frozen 20 C
NBF 10% neutral buffered formalin, NHP nonhuman primate
a Minimum recommendations in addition to standard regulatory requirements; additional backup bones can be added
b L4 + L5 (together) for mice
1.3 Tier Approach to Including Specialized Bone End-Points in Preclinical Toxicology Studies
The decision to include specialized bone end-points into toxicity studies is driven by numerous factors. These specialized techniques when used as part of a systems approach to safety assessments are normally sufficiently sensitive to detect perturbations in bone which are needed to address liability, to monitor drug pharmacology, determine the chronology of an effect, address a regulatory requirement, or provide mechanistic data to characterize an effect. In instances where markers show changes consistent with the expected pharmacology of a compound, blood sampling for pharmacokinetics can be combined with sampling for biochemical markers to establish a pharmacokinetic/pharmacodynamic (PK/PD) profile (e.g., see Ominsky et al. ). This PK/PD profiling can help guide selection of a specific marker for use in future studies and potentially to establish the optimal timing for sample collection.
Safety assessments ultimately need to provide information regarding how a drug is affecting the skeleton and whether this is a beneficial or adverse effect. When testing a compound belonging to a specific drug class with known class effects, these end-points can be used to confirm the class effect and to further characterize the drug for equivalence, superiority, or adversity. When testing a new drug with no established toxicity, based on what is known of the target or mechanism of action, standard clinical pathology parameters from acute and/or early dose-range finding studies can be monitored for perturbations in calcium/phosphorus and total alkaline phosphatase levels, as a minimum. Biochemical markers can be added to the clinical pathology analysis to facilitate hazard identification. These early data are used to drive the design of the sub-chronic and chronic studies. In studies 28 days or longer, radiography and/or bone densitometry can be added, either in vivo or ex vivo using excised bones. Radiographs are used to monitor skeletal growth (most notably in juvenile toxicology studies), assess skeletal maturity (growth plate closure), identify and/or monitor the progression of abnormalities and bone healing, and as a tool in skeletal phenotyping. Radiography has become an important end-point in rodent lifetime pharmacology or carcinogenicity studies where there is a risk for osteosarcoma; whole body radiographs obtained prior to termination are used to identify bone masses and lesions to facilitate tissue collection at necropsy and subsequent microscopic evaluation and diagnosis (Jolette et al. ). In vivo bone densitometry is highly recommended for non-rodent species where group sizes are small (typically 35/sex) and bone density can vary considerably between animals. Inclusion of baseline scans for large animals allows any changes to be determined relative to individual animal baseline data. Baseline scans are normally not required for rodent studies which typically are well powered ( n = 8 to 10/sex) and have relatively homogeneous bone density within a population. For rodent studies, adequate data for interpretation can often be obtained ex vivo. For rodent and non-rodent studies 3 months or longer, in vivo scans can be acquired at several timepoints during the study to provide a chronology of any effects.
Next page
Light

Font size:

Reset

Interval:

Bookmark:

Make

Similar books «Bone Toxicology»

Look at similar books to Bone Toxicology. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


Reviews about «Bone Toxicology»

Discussion, reviews of the book Bone Toxicology and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.